What Cardiometabolic Clinicians Can Be Thankful For This Year
Cardiometabolic Health Congress
NOVEMBER 22, 2024
The study found reductions in the apnea-hypopnea index (AHI), inflammation markers, and systolic blood pressure, making it a promising dual-purpose medication for managing obesity-related complications. Takeaways for Cardiometabolic Clinicians The past year has seen remarkable advances in the field of cardiometabolic health.
Let's personalize your content